Cargando…
Natural Autoantibodies in Chronic Pulmonary Diseases
In autoantibody-mediated autoimmune diseases, pathogenic autoantibodies generated by a failure of central or peripheral tolerance, have different effects mediated by a variety of mechanisms. Interestingly, even non-autoimmune chronic diseases have a set of disease-specific natural autoantibodies tha...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037933/ https://www.ncbi.nlm.nih.gov/pubmed/32046322 http://dx.doi.org/10.3390/ijms21031138 |
_version_ | 1783500537691373568 |
---|---|
author | Fukushima, Kiyoharu Tsujino, Kazuyuki Futami, Shinji Kida, Hiroshi |
author_facet | Fukushima, Kiyoharu Tsujino, Kazuyuki Futami, Shinji Kida, Hiroshi |
author_sort | Fukushima, Kiyoharu |
collection | PubMed |
description | In autoantibody-mediated autoimmune diseases, pathogenic autoantibodies generated by a failure of central or peripheral tolerance, have different effects mediated by a variety of mechanisms. Interestingly, even non-autoimmune chronic diseases have a set of disease-specific natural autoantibodies that are maintained for a long time. Because most of these natural autoantibodies target intracellular proteins or long non-coding RNAs, they are speculated to be non-pathological and have some important as yet unrecognized physiological functions such as debris clearance. Recently, we revealed a set of disease-specific natural autoantibodies of chronic pulmonary diseases with unknown etiology by protein arrays that enable detection of specific autoantibodies against >8000 targets. Surprisingly, some of the targeted antigens of disease-specific autoantibodies were subsequently reported by other laboratories as strongly associated with the disease, suggesting that these antigens reflect the pathology of each disease. Furthermore, some of these autoantibodies that target extracellular antigens might modify the original course of each disease. Here, we review the disease-specific natural autoantibodies of chronic pulmonary diseases, including chronic fibrosing idiopathic interstitial pneumonias, sarcoidosis, and autoimmune pulmonary alveolar proteinosis, and discuss their utility and effects. |
format | Online Article Text |
id | pubmed-7037933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70379332020-03-10 Natural Autoantibodies in Chronic Pulmonary Diseases Fukushima, Kiyoharu Tsujino, Kazuyuki Futami, Shinji Kida, Hiroshi Int J Mol Sci Review In autoantibody-mediated autoimmune diseases, pathogenic autoantibodies generated by a failure of central or peripheral tolerance, have different effects mediated by a variety of mechanisms. Interestingly, even non-autoimmune chronic diseases have a set of disease-specific natural autoantibodies that are maintained for a long time. Because most of these natural autoantibodies target intracellular proteins or long non-coding RNAs, they are speculated to be non-pathological and have some important as yet unrecognized physiological functions such as debris clearance. Recently, we revealed a set of disease-specific natural autoantibodies of chronic pulmonary diseases with unknown etiology by protein arrays that enable detection of specific autoantibodies against >8000 targets. Surprisingly, some of the targeted antigens of disease-specific autoantibodies were subsequently reported by other laboratories as strongly associated with the disease, suggesting that these antigens reflect the pathology of each disease. Furthermore, some of these autoantibodies that target extracellular antigens might modify the original course of each disease. Here, we review the disease-specific natural autoantibodies of chronic pulmonary diseases, including chronic fibrosing idiopathic interstitial pneumonias, sarcoidosis, and autoimmune pulmonary alveolar proteinosis, and discuss their utility and effects. MDPI 2020-02-08 /pmc/articles/PMC7037933/ /pubmed/32046322 http://dx.doi.org/10.3390/ijms21031138 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Fukushima, Kiyoharu Tsujino, Kazuyuki Futami, Shinji Kida, Hiroshi Natural Autoantibodies in Chronic Pulmonary Diseases |
title | Natural Autoantibodies in Chronic Pulmonary Diseases |
title_full | Natural Autoantibodies in Chronic Pulmonary Diseases |
title_fullStr | Natural Autoantibodies in Chronic Pulmonary Diseases |
title_full_unstemmed | Natural Autoantibodies in Chronic Pulmonary Diseases |
title_short | Natural Autoantibodies in Chronic Pulmonary Diseases |
title_sort | natural autoantibodies in chronic pulmonary diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037933/ https://www.ncbi.nlm.nih.gov/pubmed/32046322 http://dx.doi.org/10.3390/ijms21031138 |
work_keys_str_mv | AT fukushimakiyoharu naturalautoantibodiesinchronicpulmonarydiseases AT tsujinokazuyuki naturalautoantibodiesinchronicpulmonarydiseases AT futamishinji naturalautoantibodiesinchronicpulmonarydiseases AT kidahiroshi naturalautoantibodiesinchronicpulmonarydiseases |